Preferred Label : organophosphorus compounds;

MeSH definition : Organic compounds that contain phosphorus as an integral part of the molecule. Included under this heading is broad array of synthetic compounds that are used as PESTICIDES and DRUGS.;

MeSH synonym : compounds, organophosphorus; Organophosphorus Compound; Compound, Organophosphorus;

MeSH hyponym : organopyrophosphorus compounds; Compounds, Organopyrophosphorus; Organopyrophosphorus Compound; Compound, Organopyrophosphorus;

MeSH annotation : DF: ORGANOPHOSPHORUS CPDS;

Wikipedia link : https://en.wikipedia.org/wiki/Organophosphorus compound;

Is substance : O;

Details


Main resources

You can consult :

Organic compounds that contain phosphorus as an integral part of the molecule. Included under this heading is broad array of synthetic compounds that are used as PESTICIDES and DRUGS.

https://www.has-sante.fr/jcms/p_3164675/fr/etopophos
2020
false
false
false
France
antineoplastic agents, phytogenic
infusions, parenteral
insurance, health, reimbursement
treatment outcome
etoposide
evaluation of the transparency committee
etoposide phosphate
organophosphorus compounds
etoposide

---
https://www.has-sante.fr/jcms/p_3201262/fr/alunbrig
2020
false
false
false
France
treatment outcome
insurance, health, reimbursement
brigatinib
carcinoma, non-small-cell lung
ALK Inhibitor
Anaplastic Lymphoma Kinase
antineoplastic agents
protein kinase inhibitors
adult
brigatinib
Tyrosine Kinase Inhibitors
evaluation of the transparency committee
brigatinib
organophosphorus compounds
pyrimidines

---
https://www.has-sante.fr/jcms/p_3118131/fr/alunbrig
2019
false
false
false
France
brigatinib
brigatinib
adult
treatment outcome
insurance, health, reimbursement
antineoplastic agents
carcinoma, non-small-cell lung
administration, oral
bronchial neoplasms
evaluation of the transparency committee
brigatinib
organophosphorus compounds
pyrimidines

---
https://www.has-sante.fr/portail/jcms/c_2863546/fr/muphoran-fotemustine-nitrosouree
2019
false
false
false
France
French
infusions, intravenous
fotemustine
antineoplastic agents
melanoma
neoplasm metastasis
fotemustine
treatment outcome
clinical trials as topic
evaluation of the transparency committee
brain neoplasms
guidelines for drug use
Advanced Malignant Neoplasm
nitrosourea compounds
organophosphorus compounds

---
https://www.has-sante.fr/portail/jcms/c_2863546/fr/muphoran
2018
false
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
melanoma
fotemustine
nitrosourea compounds
organophosphorus compounds

---
https://www.ema.europa.eu/en/medicines/human/EPAR/alunbrig
2018
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
brigatinib
brigatinib
brigatinib
adult
carcinoma, non-small-cell lung
carcinoma, non-small-cell lung
mutation
administration, oral
product surveillance, postmarketing
aged
drug interactions
pregnancy
breast feeding
antineoplastic agents
antineoplastic agents
protein kinase inhibitors
protein kinase inhibitors
drug evaluation, preclinical
Tyrosine Kinase Inhibitors
organophosphorus compounds
pyrimidines
organophosphorus compounds
pyrimidines
receptor Protein-Tyrosine kinases
Anaplastic Lymphoma Kinase

---
http://www.has-sante.fr/portail/jcms/c_1758663/fr/muphoran
http://www.has-sante.fr/portail/jcms/c_400874/fr/muphoran-poudre-et-solution-pour-usage-parenteral-a-diluer-perfusion-1-flacon-en-verre-brun-de-208-mg-1-ampoules-en-verre-de-4-ml-331-870-2
2014
false
false
false
France
French
infusions, intravenous
fotemustine
antineoplastic agents
melanoma
neoplasm metastasis
brain neoplasms
fotemustine
malignant primary brain tumors
treatment outcome
clinical trials as topic
evaluation of the transparency committee
nitrosourea compounds
organophosphorus compounds

---
http://www.has-sante.fr/portail/jcms/c_1769329/fr/quadramet
2014
false
false
false
France
French
evaluation of the transparency committee
samarium Sm-153 lexidronam
analgesics, non-narcotic
radioisotopes
samarium
bone neoplasms
pain
treatment outcome
infusions, intravenous
neoplasm metastasis
lung neoplasms
prostatic neoplasms
breast neoplasms
Cancer Pain
samarium Sm-153 lexidronam
organometallic compounds
organophosphorus compounds

---
https://www.ema.europa.eu/medicines/human/EPAR/Quadramet
2012
United Kingdom
French
English
syndication feed
Cancer Pain Management
Cancer Pain
organometallic compounds
bone neoplasms
pregnancy
organophosphorus compounds
pain
injections, intravenous
radiopharmaceuticals
analgesics, non-narcotic
drug evaluation, preclinical
drug compounding
drug approval
drug labeling
samarium
Cancer Pain
Cancer pain
samarium Sm-153 lexidronam
samarium Sm-153 lexidronam
samarium (153sm) lexidronam
organometallic compounds
organometallic compounds
organophosphorus compounds
organophosphorus compounds
summary of product characteristics
drug evaluation
package leaflet

---
https://reptox.cnesst.gouv.qc.ca/pages/fiche-complete.aspx?no_produit=305458&nom=Acide+diéthylènetriaminepentaméthylènephosphonique
Canada
French
organophosphorus compounds
diethylenetriaminepenta(methylenephosphonic) acid
toxicological data sheet

---
http://www.lecrat.eu/?s=Fot%C3%A9mustine+-+exposition+paternelle
2009
France
French
nitrosourea compounds
organophosphorus compounds
antineoplastic agents
mutagens
paternal exposure
fotemustine
fotemustine
organophosphorus compounds
nitrosourea compounds
drug information

---
Nous contacter.
01/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.